MedTrace Logo

Samsung Galaxy Watch Body Composition Study

NCT05217524 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2022-02-01

No results posted yet for this study

Summary

The aim of this study is to acquire impedance measurements of the adult human body with a novel bioimpedance device housed inside a watch case and to compare derived estimates of body composition measured by dual-energy x-ray absorptiometry (DXA) and other bioimpedance analysis (BIA) systems.

Conditions

Interventions

DEVICE

Galaxy BIA watch

Digital multifunction watch

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-12-20
Completion
2022-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217524 on ClinicalTrials.gov